Stay updated on Soticlestat in Rare Epilepsies Clinical Trial
Sign up to get notified when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.

Latest updates to the Soticlestat in Rare Epilepsies Clinical Trial page
- Check6 days agoChange DetectedThe study record now includes a sponsor note that Takeda divested TAK-935-18-001 to Mistrau Bio, Inc. in 2026, and adds/updates the Study Director and Investigators sections with corresponding dates.SummaryDifference0.4%

- Check13 days agoChange DetectedThe site revision has been updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor platform update rather than a change to study content or functionality.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now includes a 2018 U.S. NIH Grant/Contract entry under Other Study ID Numbers. This addition provides funding attribution for the ENDYMION 1 study.SummaryDifference0.1%

- Check27 days agoChange DetectedNo additions or deletions were reported for this page in the provided changes feed, so the content remains unchanged based on the available data.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now displays revision v3.6.5 instead of v3.6.4, indicating a small backend/UI update to the site.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page's revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new platform release. This update reflects an internal site update and does not modify study content or user-facing information.SummaryDifference0.1%

Stay in the know with updates to Soticlestat in Rare Epilepsies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.